Berlin, Mar 30 (efe-epa).- Health officials in Berlin and Munich on Tuesday announced they were suspending the use of the AstraZeneca vaccine for people under 60.
The decision to halt the rollout comes amid new reports of blood clots forming in 31 people who had received the Anglo-Swedish vaccine, none of whom died, according to Der Spiegel.
A meeting between health officials of the federal government and the country’s regional authorities will be held on Tuesday evening to discuss the latest developments.
Several EU countries suspended administering the AstraZeneca jab this month following reports of rare but serious cases of thrombosis.
The European Medicines Agency and the World Health Organization insisted that the vaccine was safe to use and that the benefits outweighed any risks associated with getting the inoculation.
After a review, both bodies cleared the vaccine on 18 March. Germany and other countries that had halted their rollouts restarted administering the jab the next day.
According to the Robert Koch Institute, the country’s disease control center, more than 2.7 million people have received the AstraZeneca jab. EFE-EPA